NEOGENOMICS INC NEO
NEOGENOMICS INC statistics & valuation
Market cap$1.8B
P / S2.5×
P / B2.2×
Net margin-14.9%
Return on equity-12.9%
FCF margin-3.0%
Net debt$182.2M
Enterprise value USD$2.0B
Earnings yield EBIT/EV-5.7%
Return on capital-9.1%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | 46.0% | 42.4% | 42.3% |
| Operating margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | 3.6% | 1.2% | 0.9% |
| Net margin | -14.9% | -11.9% | -14.9% | -28.3% | -1.7% | 0.9% | 2.0% | 1.0% | -0.2% | -2.6% |
| FCF margin | -3.0% | -5.2% | -5.2% | -19.0% | -18.8% | -6.2% | 0.8% | 11.0% | 1.8% | 6.0% |
| Return on assets | -7.9% | -4.8% | -5.2% | -8.3% | -0.4% | 0.4% | 1.1% | 0.5% | -0.1% | -1.8% |
| Return on equity | -12.9% | -8.7% | -9.3% | -14.5% | -0.8% | 0.6% | 1.6% | 0.8% | -0.2% | -3.8% |
| Debt / equity | 0.41× | 0.60× | 0.57× | — | — | — | — | 0.32× | 0.56× | 0.60× |
| Current ratio | 4.26 | 1.98 | 6.20 | 6.73 | 7.81 | 6.13 | 4.55 | 1.70 | 2.35 | 2.07 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.